These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2995505)

  • 1. Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
    Plotkin SA; Drew WL; Felsenstein D; Hirsch MS
    J Infect Dis; 1985 Oct; 152(4):833-4. PubMed ID: 2995505
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferons.
    Rasmussen L; Chen PT; Mullenax JG; Merigan TC
    Antimicrob Agents Chemother; 1984 Oct; 26(4):441-5. PubMed ID: 6097163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ganciclovir [9-(1,3-dihydroxy-2-propoxymethyl)] guanine. A new antiviral agent against Cytomegalovirus].
    Petersen CS; Skinhøj P
    Ugeskr Laeger; 1989 Aug; 151(34):2156-8. PubMed ID: 2773153
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegaloviruses.
    Duke AE; Smee DF; Chernow M; Boehme R; Matthews TR
    Antiviral Res; 1986 Aug; 6(5):299-308. PubMed ID: 3021055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovir.
    Cole NL; Balfour HH
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):255-61. PubMed ID: 3032503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro.
    Mar EC; Cheng YC; Huang ES
    Antimicrob Agents Chemother; 1983 Oct; 24(4):518-21. PubMed ID: 6316844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses.
    Freitas VR; Smee DF; Chernow M; Boehme R; Matthews TR
    Antimicrob Agents Chemother; 1985 Aug; 28(2):240-5. PubMed ID: 3010840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity and mechanism of action of ganciclovir.
    Matthews T; Boehme R
    Rev Infect Dis; 1988; 10 Suppl 3():S490-4. PubMed ID: 2847285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegalovirus infection in a guinea pig model.
    Fong CK; Cohen SD; McCormick S; Hsiung GD
    Antiviral Res; 1987 Jan; 7(1):11-23. PubMed ID: 3026243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine structure of cells infected with human cytomegalovirus after treatment with 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
    Mobberley MA; Ryder TA; Hart H; Tyms AS
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1553-62. PubMed ID: 3035059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ganciclovir [9-(1,3-dihydroxy-2-propoxymethyl)guanine] on viral DNA and protein synthesis in cells infected with herpes simplex virus.
    Chun YS; Park NH
    Antimicrob Agents Chemother; 1987 Feb; 31(2):349-51. PubMed ID: 3032100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients.
    Erice A; Chou S; Biron KK; Stanat SC; Balfour HH; Jordan MC
    N Engl J Med; 1989 Feb; 320(5):289-93. PubMed ID: 2536135
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the cytotoxicity of a new anti-herpetic agent, 9-(1,3-dihydroxy-2-propoxymethyl) guanine, on the rabbit cornea].
    Naito T; Shiota H; Kanematsu S; Mimura Y; Ogawa T
    Nippon Ganka Gakkai Zasshi; 1988 Apr; 92(4):573-7. PubMed ID: 2841833
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and antiviral activity of 3-substituted derivatives of 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purines, tricyclic analogues of acyclovir and ganciclovir.
    Boryski J; Golankiewicz B; De Clercq E
    J Med Chem; 1991 Aug; 34(8):2380-3. PubMed ID: 1652016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
    de Hemptinne B; Lamy ME; Salizzoni M; Cornu C; Mostin J; Fevery J; De Groote V; Otte JB
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to antiviral drugs at last.
    N Z Med J; 1989 Sep; 102(875):487. PubMed ID: 2550860
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of cytomegalovirus infections in renal transplant recipients with 9-(1,3-dihydroxy-2-propoxymethyl) guanine.
    Cantarovich M; Hiesse C; Lantz O; Fassi-Fihri S; Charpentier B; Fries D
    Transplantation; 1988 Jun; 45(6):1139-41. PubMed ID: 2837848
    [No Abstract]   [Full Text] [Related]  

  • 18. Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir.
    Russler SK; Tapper MA; Carrigan DR
    Lancet; 1989 Aug; 2(8659):382. PubMed ID: 2569565
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
    Mar EC; Chiou JF; Cheng YC; Huang ES
    J Virol; 1985 Mar; 53(3):776-80. PubMed ID: 2983088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis.
    Woolf NK; Ochi JW; Silva EJ; Sharp PA; Harris JP; Richman DD
    Antimicrob Agents Chemother; 1988 Jun; 32(6):865-72. PubMed ID: 2843084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.